UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000015020
Receipt No. R000017468
Official scientific title of the study Effects of the indomethacin spray in patient with radiation-induced oral mucositis (Rondomised,double blind, placebo controlled crossover study)
Date of disclosure of the study information 2014/09/30
Last modified on 2018/09/04 (Ver. 6)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Effects of the indomethacin spray in patient with radiation-induced oral mucositis (Rondomised,double blind, placebo controlled crossover study)
Title of the study (Brief title) Effects of the indomethacin spray in patient with radiation-induced oral mucositis
Region
Japan

Condition
Condition Head and neck cancer patients with radiation induced oral mucositis
Classification by specialty
Dental medicine
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 Examine the efficacy of the indomethacin spray for radiation induced oral mucositis
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1 Confirmatory
Trial characteristics_2
Developmental phase Not applicable

Assessment
Primary outcomes analgesic effect of the indomethacin spray for radiation induced oral mucositis
(VAS after 30 minutes)
Key secondary outcomes Safty of indomethacin spray for radiation induced oral mucositis

Base
Study type Interventional

Study design
Basic design Cross-over
Randomization Randomized
Randomization unit Individual
Blinding Double blind -all involved are blinded
Control Placebo
Stratification NO
Dynamic allocation YES
Institution consideration Institution is not considered as adjustment factor.
Blocking NO
Concealment Central registration

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 administration of indomethacin spray
Interventions/Control_2 administration of placebo
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria 1)The patient of oropharyngeal cancer or maxillary or oral cancer.
2)The patient with oral mucositis (>Gr.1 NCI CTCAE Ver.3) and pain (>VAS50mm)
3)Indomethacin spray is available
4)Perfomance status(ECOG) 0 or 1.
5)Over 20 age (at the time of the agreement acquisition).
Key exclusion criteria 1)Patient with serious comorbidities.
2)Patient with Gr.2 or more mucositis but no pain.
3)During(or Planning of) the study of a clinical experimental medicine.
4)Contraindication of NSAIDs
5)Patient whom the chief physician or principal investigator judged to be inappropriate.
Target sample size 54

Research contact person
Name of lead principal investigator Yoshimasa Kitagawa
Organization Department of oral pathobiological Science, Graduate school of dental medicine , Hokkaido University
Division name Oral diagnosis and medicine
Address Kita13jyo Nishi7chome KIta-Ku Sapporo
TEL 0117064280
Email hata@den.hokudai.ac.jp

Public contact
Name of contact person Hironobu Hata
Organization Department of oral pathobiological Science, Graduate school of dental medicine , Hokkaido University
Division name Oral diagnosis and medicine
Address Kita13jyo Nishi7chome KIta-Ku Sapporo
TEL 0117064280
Homepage URL
Email hata@den.hokudai.ac.jp

Sponsor
Institute Graduate school of dental medicine , Hokkaido University
Institute
Department

Funding Source
Organization Graduate school of dental medicine , Hokkaido University
Organization
Division
Category of Funding Organization Japanese Governmental office
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2014 Year 09 Month 30 Day

Progress
Recruitment status Completed
Date of protocol fixation
2014 Year 09 Month 02 Day
Anticipated trial start date
2014 Year 10 Month 01 Day
Last follow-up date
Date of closure to data entry
2018 Year 02 Month 28 Day
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2014 Year 09 Month 02 Day
Last modified on
2018 Year 09 Month 04 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000017468